Act Capital Management, LLC Cardiff Oncology, Inc. Transaction History
Act Capital Management, LLC
- $72.5 Million
- Q3 2022
A detailed history of Act Capital Management, LLC transactions in Cardiff Oncology, Inc. stock. As of the latest transaction made, Act Capital Management, LLC holds 120,600 shares of CRDF stock, worth $424,512. This represents 0.26% of its overall portfolio holdings.
Number of Shares
120,600
Previous 120,600
-0.0%
Holding current value
$424,512
Previous $265,000
29.81%
% of portfolio
0.26%
Previous 0.37%
Shares
2 transactions
Others Institutions Holding CRDF
# of Institutions
91Shares Held
12.1MCall Options Held
813KPut Options Held
91.1K-
Black Rock Inc. New York, NY2.63MShares$9.25 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.17MShares$7.64 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA928KShares$3.27 Million0.0% of portfolio
-
State Street Corp Boston, MA833KShares$2.93 Million0.0% of portfolio
-
Mai Capital Management663KShares$2.34 Million0.02% of portfolio
About Cardiff Oncology, Inc.
- Ticker CRDF
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,334,900
- Market Cap $153M
- Description
- Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...